Bone Biologics Corp Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Bone Biologics Corp quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Bone Biologics Corp Debt-to-equity for the quarter ending September 30, 2024 was 11.7 %, a 78% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 11.7 -41.4 -78% Sep 30, 2024
Q2 2024 18.6 -30.8 -62.4% Jun 30, 2024
Q1 2024 25.6 -14.1 -35.6% Mar 31, 2024
Q4 2023 52.5 +36.7 +232% Dec 31, 2023
Q3 2023 53.1 +48.6 +1072% Sep 30, 2023
Q2 2023 49.4 -451 -90.1% Jun 30, 2023
Q1 2023 39.7 +215 Mar 31, 2023
Q4 2022 15.8 +134 Dec 31, 2022
Q3 2022 4.53 +105 Sep 30, 2022
Q2 2022 501 +601 Jun 30, 2022
Q1 2022 -175 -74.8 -74.6% Mar 31, 2022
Q4 2021 -118 -18.2 -18.2% Dec 31, 2021
Q3 2021 -100 -0.14 -0.14% Sep 30, 2021
Q2 2021 -100 Jun 30, 2021
Q1 2021 -100 Mar 31, 2021
Q4 2020 -100 Dec 31, 2020
Q3 2020 -100 Sep 30, 2020
Q4 2018 -113 +1.37 +1.2% Dec 31, 2018
Q3 2018 -112 +1.78 +1.57% Sep 30, 2018
Q2 2018 -109 +3.23 +2.88% Jun 30, 2018
Q1 2018 -110 +8.93 +7.49% Mar 31, 2018
Q4 2017 -114 +20 +15% Dec 31, 2017
Q3 2017 -114 +39.2 +25.7% Sep 30, 2017
Q2 2017 -112 +74.3 +39.8% Jun 30, 2017
Q1 2017 -119 +124 +51% Mar 31, 2017
Q4 2016 -134 +83.6 +38.4% Dec 31, 2016
Q3 2016 -153 +76.7 +33.4% Sep 30, 2016
Q2 2016 -187 +1.14 +0.61% Jun 30, 2016
Q1 2016 -243 -103 -73.4% Mar 31, 2016
Q4 2015 -218 -87 -66.7% Dec 31, 2015
Q3 2015 -230 -126 -121% Sep 30, 2015
Q2 2015 -188 -85.9 -84.4% Jun 30, 2015
Q1 2015 -140 -38.7 -38.1% Mar 31, 2015
Q4 2014 -131 -29 -28.5% Dec 31, 2014
Q3 2014 -104 -101 -3130% Sep 30, 2014
Q2 2014 -102 -98.7 -3168% Jun 30, 2014
Q1 2014 -102 -98.5 -3284% Apr 30, 2014
Q4 2013 -102 -98.7 -3422% Dec 31, 2013
Q3 2013 -3.22 +0.02 +0.62% Oct 31, 2013
Q2 2013 -3.11 -0.03 -0.97% Jul 31, 2013
Q1 2013 -3 -0.06 -2.04% Apr 30, 2013
Q4 2012 -2.88 Jan 31, 2013
Q3 2012 -3.23 Oct 31, 2012
Q2 2012 -3.09 Jul 31, 2012
Q1 2012 -2.94 Apr 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.